Evaluating psychosocial and best supportive care needs of cancer patients from rural regions following active cancer therapy for improving quality of life and therapeutic management

Not Applicable

Completed

• Conditions: Cancer; Tumour groups, stages and therapies required; Psychosocial concerns for patients following active therapy; Mental Health - Anxiety; Mental Health - Depression; Cancer - Any cancer

• Registration Number: ACTRN12613001309774
• Lead Sponsor: The Riverina Cancer Care Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Adult patients older than, 18 years of age
Histological proven cancer (all tumour types)
Male or Female
Ability to comprehend questionnaire alone (or in juxtaposition with proxy, from commencement, in specific patients with acutely declining trajectory prediction)
Willingness to participate in a questionnaire-based study
Informed consent
Completed therapy during final two weeks of recruitment

Exclusion Criteria

Life expectancy predicted to be less than 6 months if not assisted by proxy/carer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gain an understanding of what is being experienced by individuals following cancer treatment, to inform the creation of a survivorship care plan (SCP) dedicated to the psychosocial and best supportive care needs of the individual.<br>This outcome will be achieved using questionnaires and interviews.<br><br>The questionnaires used are PROMIS29 and the Distress Thermometer and will be analysed according to the scoring tools for each test with in-built result calculators.<br>The interviews will be coded and a Grounded Theory technique used to evaluate the needs of patients.[On completion of active therapy]

Secondary Outcome Measures

Name	Time	Method
To determine differences in needs between tumour groups and histological stages.<br>Statistical analysis tools used will be the t-test to compare the actual difference between the two means in relation to the variation in the data (different tumour groups). The p-test will be used to determine the probability of obtaining a test statistic at least as extreme as the one that was actually observed.<br>[3 months and 6 months or 4+ years following active therapy]